Correction to: npj Vaccines https://doi.org/10.1038/s41541-021-00307-6, published online 09 April 2021
A number of authors were mistakenly omitted from the original version of this Article. The HTML and PDF versions of the Article have now been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Saunders, K.O., Pardi, N., Parks, R. et al. Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates. npj Vaccines 6, 136 (2021). https://doi.org/10.1038/s41541-021-00397-2
Published:
Version of record:
DOI: https://doi.org/10.1038/s41541-021-00397-2
